Inicio>>Signaling Pathways>> Apoptosis>>GPNA hydrochloride

GPNA hydrochloride

Catalog No.GC39489

El clorhidrato de GPNA es un sustrato bien conocido de la enzima γ-glutamiltransferasa (GGT). El clorhidrato de GPNA es un inhibidor especÍfico de ASCT2 del transportador de glutamina (Gln). El clorhidrato de GPNA también inhibe los transportadores dependientes de Na+-, como la familia SNAT (SNAT1/2/4/5), y los transportadores de leucina independientes de Na+- LAT1/2. GPNA induce reversiblemente la apoptosis en células A549.

Products are for research use only. Not for human use. We do not sell to patients.

GPNA hydrochloride Chemical Structure

Cas No.: 67953-08-6

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
57,00 $
Disponible
10mg
52,00 $
Disponible
50mg
153,00 $
Disponible
100mg
209,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

GPNA hydrochloride is a well known substrate of the enzyme γ-glutamyltransferase (GGT). GPNA hydrochloride is a specific glutamine (Gln) transporter ASCT2 inhibitor. GPNA hydrochloride also inhibit Na+-dependent carriers, such as SNAT family (SNAT1/2/4/5), and the Na+-independent leucine transporters LAT1/2. GPNA reversibly induces apoptosis in A549 cells[1].

[1]. Corti A, et al. γ-Glutamyltransferase enzyme activity of cancer cells modulates L-γ-glutamyl-p-nitroanilide (GPNA) cytotoxicity. Sci Rep. 2019 Jan 29;9(1):891.

Reseñas

Review for GPNA hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GPNA hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.